| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |